GRP
MYGN icon

Global Retirement Partners’s Myriad Genetics MYGN Stock Holding History

Global Retirement Partners’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18
Closed -$282 – 3433
2023
Q3 		$282 Hold
18
– – ﹤0.01% 3076
2023
Q2 		$417 Hold
18
– – ﹤0.01% 2987
2023
Q1 		$394 Hold
18
– – ﹤0.01% 2974
2022
Q4 		$261 Hold
18
– – ﹤0.01% 2911
2022
Q3 		$0 Sell
18
-22
-55% -$505 ﹤0.01% 2876
2022
Q2 		$1K Buy
40
+3
+8% +$62 ﹤0.01% 2486
2022
Q1 		$1K Buy
+37
New +$947 ﹤0.01% 2453

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Global Retirement Partners's MYGN Position: Q4 2023 in Review

Global Retirement Partners sold out of Myriad Genetics (MYGN) in Q4 2023, closing a stake of 18 shares — an estimated $282 sold.

Global Retirement Partners first reported a position in MYGN in Q1 2022 and held it in 7 quarters. The position peaked at $1K in Q2 2022. 194 funds tracked by Wall St. Rank hold MYGN as of Q4 2023.

  • Global Retirement Partners reported no remaining Myriad Genetics position as of Q4 2023 after selling out during the quarter.
  • Global Retirement Partners sold 18 Myriad Genetics shares in Q4 2023, an estimated $282.
  • Global Retirement Partners first reported a position in Myriad Genetics in Q1 2022 and held it in 7 quarters.
  • Global Retirement Partners's Myriad Genetics position peaked at $1K in Q2 2022.
  • 194 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2023.

Based on Global Retirement Partners's 13F filing for Q4 2023, filed 18 Jan 2024.